Finance

Lists
PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
US$ ८.७८
+४.७७%
(+०.४०) 1D
अगस्ट १०, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PTKFY...
Open
US$ ८.७८
High
US$ ८.७८
Low
US$ ८.७८
Mkt. cap
३.७७ शंख
Avg. vol.
६५०.००
Volume
८५५.००
52-wk high
US$ १८.५९
52-wk low
US$ ७.६३
Beta
०.०५
Shares outstanding
२३.४१ करोड
No. of employees
१३ हजार
Open
US$ ८.७८
High
US$ ८.७८
Low
US$ ८.७८
Mkt. cap
३.७७ शंख
Avg. vol.
६५०.००
Volume
८५५.००
52-wk high
US$ १८.५९
52-wk low
US$ ७.६३
Beta
०.०५
Shares outstanding
२३.४१ करोड
No. of employees
१३ हजार
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient. Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar. Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About PT Kalbe Farma Unsponsored Indonesia ADR
CEO-
Employees१२.८ हजार
Founded१९६६ सेप्टेम्बर १०
Headquarters-
Sector-
Websitekalbe.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
८९.०९ खरब
९३.३६ खरब
९६.७८ खरब
९८.०० खरब
Cost of goods sold
५४.६० खरब
५९.१७ खरब
६०.२४ खरब
६२.४७ खरब
Cost of revenue
५४.६० खरब
५९.१७ खरब
६०.२४ खरब
६२.४७ खरब
Research and development expenses
९८.३१ अरब
१.६१ खरब
१.१३ खरब
१.२३ खरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.०६ खरब
१९.४६ खरब
२२.२९ खरब
२२.६६ खरब
Operating expense
२५.९७ खरब
२१.३८ खरब
२३.३२ खरब
२३.९१ खरब
Total operating expenses
८०.५७ खरब
८०.५५ खरब
८३.५६ खरब
८६.३८ खरब
Operating income
८.५२ खरब
१२.८१ खरब
१३.२२ खरब
११.६३ खरब
Other non operating income
-३.७८ अरब
-४.१७ अरब
-३.६३ अरब
-३.७४ अरब
EBT including unusual items
८.७८ खरब
१३.०२ खरब
१३.५७ खरब
११.९१ खरब
EBT excluding unusual items
८.८९ खरब
१३.०० खरब
१३.५७ खरब
११.७८ खरब
Income tax expense
२.११ खरब
२.५३ खरब
३.०४ खरब
२.७२ खरब
Effective tax rate
२४.०६%
१९.४१%
२२.४०%
२२.८०%
Other operating expenses
-७.२३ अरब
३१.३५ अरब
-१०.०२ अरब
२.१३ अरब
Net income
६.५६ खरब
१०.३४ खरब
१०.२९ खरब
८.९१ खरब
Net profit margin
७.३७%
११.०७%
१०.६३%
९.०९%
Earnings per share
१४.४४
२२.७२
२२.७४
१९.६८
Interest and investment income
४१.३१ अरब
४०.४३ अरब
३२.०७ अरब
४३.६१ अरब
Interest expense
-९.६९ अरब
-५.७७ अरब
-४.६१ अरब
-६.७८ अरब
Net interest expenses
३१.६२ अरब
३४.६६ अरब
२७.४६ अरब
३६.८३ अरब
Depreciation and amortization charges
-
-
-
-
EBITDA
१०.४७ खरब
१४.६८ खरब
१५.१४ खरब
११.९७ खरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू